Literature DB >> 8797936

Immunohistochemical study of arginase in cancer of the stomach.

C W Wu1, W W Chung, C W Chi, H L Kao, W Y Lui, F K P'eng, S R Wang.   

Abstract

High levels of arginase have been detected in gastric adenocarcinoma. To examine the hypothesis that this is due to macrophage infiltration into the tumour, we localized the cellular distribution of arginase by immunohistochemical staining. We examined gastric adenocarcinomas and their corresponding normal tissues (n = 45), leiomyomas (n = 2), leiomyosarcomas (n = 3), human gastric adenocarcinoma cell lines (n = 3), and benign gastric ulcers (n = 4) by the avidin-biotin-peroxidase complex technique. Macrophages with strong arginase immunoreactivity were observed infiltrating both gastric normal and cancer tissues. No arginase immunoreactivity was observed in normal mucosal gland, muscular and serosal tissues or benign gastric ulcers. The immunoreactivity of arginase was positive but heterogeneous in most specimens of gastric adenocarcinoma (62.2%) and was absent from gastric intestinal metaplasia, leiomyomas and leiomyosarcomas. Among the 28 neoplasms with arginase immunoreactivity, scattered immunoreactivity was also noted in adjacent dysplastic glands in 12 (42.8%) specimens. Arginase immunoreactivity was observed in all three gastric cancer cell lines. Arginase is present in the cytoplasm but not in the nucleus. These data suggest that the high arginase levels in adenocarcinoma cancer tissues originate largely from cancer cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8797936     DOI: 10.1007/bf00202199

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  21 in total

1.  Regulation of arginase production by glucocorticoid in three human gastric cancer cell lines.

Authors:  C W Wu; S R Wang; S L Chien; T H Yeh; S L Lian; N Shimizu; W Y Lui; F K P'eng; C W Chi
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

2.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

3.  Evidence that an immunosuppressive protein from murine liver is arginase.

Authors:  M H Huang; C L Yu; S H Han; B N Chiang; S R Wang
Journal:  Biomed Biochim Acta       Date:  1990

4.  Content of glucocorticoid receptor and arginase in gastric cancer and normal gastric mucosal tissues.

Authors:  C W Wu; S R Wang; T J Chang; E C Lin; K L Chang; M H Huang; W Y Lui; F K P'eng; C W Chi
Journal:  Cancer       Date:  1989-12-15       Impact factor: 6.860

5.  Clinical significance of arginase in colorectal cancer.

Authors:  S Y Leu; S R Wang
Journal:  Cancer       Date:  1992-08-15       Impact factor: 6.860

6.  Establishment of cultured cell lines derived from a human gastric carcinoma.

Authors:  M Sekiguchi; K Sakakibara; G Fujii
Journal:  Jpn J Exp Med       Date:  1978-02

7.  Immunodiffusion studies on human liver and erythrocyte arginases.

Authors:  J Cabello; V Prajoux; M Plaza
Journal:  Biochim Biophys Acta       Date:  1965-09-20

8.  Serum arginase level in patients with gastric cancer.

Authors:  C W Wu; C W Chi; E C Lin; W Y Lui; F K P'eng; S R Wang
Journal:  J Clin Gastroenterol       Date:  1994-01       Impact factor: 3.062

9.  Plasma arginase concentration measured by an enzyme-linked immunosorbent assay (ELISA) in normal adult population.

Authors:  S R Wang; M L Chen; M H Huang; H Y Lin; J J Tsai; B I Kuo
Journal:  Clin Biochem       Date:  1993-12       Impact factor: 3.281

10.  Modulation of lymphocyte proliferation by murine liver extract.

Authors:  H L Su; M H Huang; C L Yu; S H Han; B N Chiang; S R Wang
Journal:  Asian Pac J Allergy Immunol       Date:  1987-06       Impact factor: 2.310

View more
  10 in total

1.  Conjugated linoleic acid isomers modulate protein expression profile in rat hepatocytes.

Authors:  E Rossi; L Della Casa; S Piana; A Iannone
Journal:  Genes Nutr       Date:  2012-05-05       Impact factor: 5.523

2.  Helicobacter pylori rocF is required for arginase activity and acid protection in vitro but is not essential for colonization of mice or for urease activity.

Authors:  D J McGee; F J Radcliff; G L Mendz; R L Ferrero; H L Mobley
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

3.  Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India.

Authors:  Biswadeep Choudhury; Shilpee Srivastava; Haider H Choudhury; Alokananda Purkayastha; Sumita DuttaGupta; Sankar Kumar Ghosh
Journal:  Tumour Biol       Date:  2014-04-09

4.  Helicobacter pylori arginase mutant colonizes arginase II knockout mice.

Authors:  Songhee H Kim; Melanie L Langford; Jean-Luc Boucher; Traci L Testerman; David J McGee
Journal:  World J Gastroenterol       Date:  2011-07-28       Impact factor: 5.742

5.  Human gastric cancer kinase profile and prognostic significance of MKK4 kinase.

Authors:  C W Wu; A F Li; C W Chi; C L Huang; K H Shen; W Y Liu; W Lin
Journal:  Am J Pathol       Date:  2000-06       Impact factor: 4.307

Review 6.  Arginase: an emerging key player in the mammalian immune system.

Authors:  Markus Munder
Journal:  Br J Pharmacol       Date:  2009-09-17       Impact factor: 8.739

Review 7.  Prevention and treatment of cancers by immune modulating nutrients.

Authors:  Naveena B Janakiram; Altaf Mohammed; Venkateshwar Madka; Gaurav Kumar; Chinthalapally V Rao
Journal:  Mol Nutr Food Res       Date:  2016-03-09       Impact factor: 5.914

8.  Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis.

Authors:  Wenjun Cao; Bill Sun; Mark A Feitelson; Tong Wu; Ran Tur-Kaspa; Qishi Fan
Journal:  Int J Cancer       Date:  2009-06-15       Impact factor: 7.396

Review 9.  Metabolism of Amino Acids in Cancer.

Authors:  Zhen Wei; Xiaoyi Liu; Chunming Cheng; Wei Yu; Ping Yi
Journal:  Front Cell Dev Biol       Date:  2021-01-12

10.  Differential gene-expression profiles associated with gastric adenoma.

Authors:  H Takenawa; M Kurosaki; N Enomoto; Y Miyasaka; N Kanazawa; N Sakamoto; T Ikeda; N Izumi; C Sato; M Watanabe
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.